Acadia Healthcare Company Inc (ACHC) : Philadelphia Financial Management Of San Francisco added new position in Acadia Healthcare Company Inc during the most recent quarter end. The investment management firm now holds 297,100 shares of Acadia Healthcare Company Inc which is valued at $15,615,576 , the company said in a statement filed on Aug 15, 2016 with the SEC.Acadia Healthcare Company Inc makes up approximately 3.36% of Philadelphia Financial Management Of San Francisco’s portfolio.
Other Hedge Funds, Including , Guggenheim Capital reduced its stake in ACHC by selling 2,109 shares or 30.14% in the most recent quarter. The Hedge Fund company now holds 4,888 shares of ACHC which is valued at $256,913.Bokf Na reduced its stake in ACHC by selling 1,293 shares or 2.43% in the most recent quarter. The Hedge Fund company now holds 51,838 shares of ACHC which is valued at $2,724,605. Acadia Healthcare Company Inc makes up approx 0.09% of Bokf Na’s portfolio.Aperio Group boosted its stake in ACHC in the latest quarter, The investment management firm added 607 additional shares and now holds a total of 6,639 shares of Acadia Healthcare Company Inc which is valued at $348,946.Thompson Davis reduced its stake in ACHC by selling 12 shares or 4.11% in the most recent quarter. The Hedge Fund company now holds 280 shares of ACHC which is valued at $14,484. Acadia Healthcare Company Inc makes up approx 0.02% of Thompson Davis’s portfolio. Three Peaks Capital Management sold out all of its stake in ACHC during the most recent quarter. The investment firm sold 24,316 shares of ACHC which is valued $1,274,888.
Acadia Healthcare Company Inc closed down -0.86 points or -1.68% at $50.33 with 7,25,570 shares getting traded on Thursday. Post opening the session at $51.43, the shares hit an intraday low of $50.2 and an intraday high of $51.44 and the price fluctuated in this range throughout the day.Shares ended Thursday session in Red.
On the company’s financial health, Acadia Healthcare Company Inc reported $0.73 EPS for the quarter, based on the information available during the earnings call on Jul 29, 2016. Analyst had a consensus estimate of $0.73. The company had revenue of $756.55 million for the quarter, compared to analysts expectations of $754.90 million. The company’s revenue was up 66.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.57 EPS.
Many Wall Street Analysts have commented on Acadia Healthcare Company Inc. Shares were Reiterated by RBC Capital Mkts on Aug 1, 2016 to “Outperform” and Lowered the Price Target to $ 78 from a previous price target of $86 .
Acadia Healthcare Company Inc. is a provider of behavioral healthcare services. The Company develops and operates inpatient psychiatric facilities residential treatment centers group homes substance abuse facilities and facilities providing outpatient behavioral healthcare services to serve the behavioral health and recovery needs of communities. It operates in two segments: U.S. Facilities and U.K. Facilities. Its U.S. Facilities and services are classified into categories which includes acute inpatient psychiatric facilities; specialty treatment facilities; residential treatment centers; and outpatient community-based services. In the United Kingdom it provides inpatient services through mental health hospitals and care homes. In addition to these services it also operates a U.K. division to provide EAP to organizations. The Company operated approximately 78 behavioral healthcare facilities with over 5800 beds in approximately 24 states the United Kingdom and Puerto Rico.